- Home
- ABL vs RXST Comparison
ABL vs RXST Comparison
Compare ABL & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABL | RXST |
|---|---|---|
| Founded | 2004 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 567.9M | 524.6M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ABL | RXST |
|---|---|---|
| Price | $8.65 | $12.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 11 |
| Target Price | ★ $12.00 | $11.30 |
| AVG Volume (30 Days) | 764.9K | ★ 884.6K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $196,551,131.00 | $142,085,000.00 |
| Revenue This Year | $95.83 | N/A |
| Revenue Next Year | $19.67 | $4.18 |
| P/E Ratio | $71.76 | ★ N/A |
| Revenue Growth | ★ 91.93 | 10.75 |
| 52 Week Low | $4.60 | $6.32 |
| 52 Week High | $9.61 | $38.64 |
Technical Indicators
Market Signals| Indicator | ABL | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 70.96 | 56.92 |
| Support Level | $8.17 | $12.07 |
| Resistance Level | $8.88 | $13.14 |
| Average True Range (ATR) | 0.41 | 0.67 |
| MACD | 0.11 | -0.11 |
| Stochastic Oscillator | 86.23 | 40.70 |
Price Performance
Historical ComparisonAbout ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.